SP-100030

N/A

Report date: 2024/01/25 09:18:05

Base Information

Drug NameSP-100030
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsTranscription factor AP1 inhibitors
TargetsNuclear factor NF-kappa-B complexTranscription factor AP1
Therapy Area/IndicationsPulmonary Fibrosis +[2] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEuropeJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBio-Signal Group Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPulmonary Fibrosis +[2] 

Other Information

ATC CodeN/A
Related LinksN/A